AI
DCPH

AdvisorShares Investments’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

AdvisorShares Investments’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-718
Closed -$9K – 349
2022
Q2 		$9K Buy
+718
New +$7.92K ﹤0.01% 219

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

AdvisorShares Investments's DCPH Position: Q3 2022 in Review

AdvisorShares Investments sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2022, closing a stake of 718 shares — an estimated $9K sold.

AdvisorShares Investments first reported a position in DCPH in Q2 2022 and held it in 1 quarter. The position peaked at $9K in Q2 2022. 150 funds tracked by Wall St. Rank hold DCPH as of Q3 2022.

  • AdvisorShares Investments reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • AdvisorShares Investments sold 718 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2022, an estimated $9K.
  • AdvisorShares Investments first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • AdvisorShares Investments's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $9K in Q2 2022.
  • 150 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on AdvisorShares Investments's 13F filing for Q3 2022, filed 14 Nov 2022.